Carsgen Therapeutics Holding Forecast, price target & analysts
Carsgen Therapeutics Holding Target price 2026 - Analyst rating & recommendation
Carsgen Therapeutics Holding Classifications & Recommendation
Carsgen Therapeutics Holding Price Target
| Target Price | HK$18.68 |
| Price | HK$11.63 |
| Potential |
60.59%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Carsgen Therapeutics Holding 2027 .
The average Carsgen Therapeutics Holding target price is HK$18.68.
This is
60.59%
register free of charge
HK$23.94
105.85%
register free of charge
HK$13.96
20.02%
register free of charge
|
|
| A rating was issued by 9 analysts: 7 Analysts recommend Carsgen Therapeutics Holding to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Carsgen Therapeutics Holding stock has an average upside potential 2027 of
60.59%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million HK$ | 147.36 | 354.33 |
| 218.75% | 140.45% | |
| EBITDA Margin | -157.89% | -68.02% |
| 87.20% | 56.92% | |
| Net Margin | -77.88% | -52.06% |
| 96.15% | 33.15% |
5 Analysts have issued a sales forecast Carsgen Therapeutics Holding 2026 . The average Carsgen Therapeutics Holding sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Carsgen Therapeutics Holding EBITDA forecast 2026. The average Carsgen Therapeutics Holding EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Carsgen Therapeutics Holding Analysts have issued a net profit forecast 2026. The average Carsgen Therapeutics Holding net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | -0.21 | -0.31 |
| 87.57% | 47.62% | |
| P/E | negative | |
| EV/Sales | 16.09 |
5 Analysts have issued a Carsgen Therapeutics Holding forecast for earnings per share. The average Carsgen Therapeutics Holding EPS is
This results in the following potential growth metrics and future valuations:
Carsgen Therapeutics Holding...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
